SENP3 promotes tumor progression and is a novel prognostic biomarker in triple-negative breast cancer

SENP3 promotes tumor progression and is a novel prognostic biomarker in triple-negative breast cancer

BackgroundThe clinical outcome of triple-negative breast cancer (TNBC) is poor. Finding more targets for the treatment of TNBC is an urgent need. SENPs are SUMO-specific proteins that play an important role in SUMO modification. Among several tumor types, SENPs have been identified as relevant bioma...

Full description

Bibliographic Details
Main Authors: Youzhi Zhu, Jiasheng Zhang, Liangfei Yu, Sunwang Xu, Ling Chen, Kunlin Wu, Lingjun Kong, Wei Lin, Jiajie Xue, Qingshui Wang, Yao Lin, Xiangjin Chen
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-01-01
Series:Frontiers in Oncology
Subjects:
TNBC
SENP family
SENP3
WGCNA
prognosis
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2022.972969/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2022.972969/full

Similar Items